Cookies and the protection of your data

We use cookies to improve the functionality of the website, to offer you a better website experience and to provide social media features. You give your consent by clicking on “Accept all Cookies” or as part of your individual settings. Please find detailed information on the use of cookies on this website in our Data Privacy Statement.

Functional Cookies

These cookies are necessary for the operation of the site and enable security-relevant functions. In addition, we determine whether you want to remain logged in and to make our services available to you when you change between this and other websites.

Statistical Cookies

These cookies are used for analyzing user behavior on our website with the aim of improving user navigation. All data collected is evaluated anonymously. Further information is available on our data protection site.

Marketing Cookies

These cookies are used to deliver relevant advertising or to limit how many times you see an ad. Marketing cookies can share that information with the advertiser (third-party cookies). The legal basis for the data processing is the consent of the user.

FibroScan PRO
FibroScan PRO
FibroScan PRO
FibroScan PRO
2018

Share:

FibroScan PRO

Medical device

FibroScan PRO is a unique medical device used in research and clinical practice to assess liver health status in patients with chronic liver diseases. It measures liver fibrosis and liver steatosis. The method is non-invasive and painless. It requires only a few minutes and is very well accepted by patients. It is based on a disruptive and patented technology: Vibration-Controlled Transient Elastography (VCTE). Its front drawer can store probes, coupling agents and wipes in a safer and more hygienic way; the screen can be adjusted flexibly and the control panel offers related shortcuts, resulting in significantly improved work efficiency.

Client / Manufacturer

Echosens Shenzhen Healthcare Co., Ltd.

Shenzhen, CN
Design

ND Industrial Design Co., Ltd.

Shenzhen, CN
Date of Launch
2018
Development Time
25 - 36 months
Target Regions
Asia
Target Groups
Other target groups: doctors & patients, Specific sub-group: doctors & patients

RELATED PROJECTS